Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. - Wikidata - awgldk - TriplyDB

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.

http://www.wikidata.org/entity/Q34719734

about

Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy Minority drug-resistant HIV-1 variants in treatment naïve East-African and Caucasian patients detected by allele-specific real-time PCR A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.Mutation detection using ENDO1: application to disease diagnostics in humans and TILLING and Eco-TILLING in plants.Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.Efficient and unbiased metagenomic recovery of RNA virus genomes from human plasma samples.Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing Minority variants of drug-resistant HIV.A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1.Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype C.Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID Population-based human immunodeficiency virus 1 drug resistance profiles among individuals who experienced virological failure to first-line antiretroviral therapy in Henan, China during 2010-2011 Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations.Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy.Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing.Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART).Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes.

P2860

Q28469253-21503C76-21E1-4AFF-91AF-B782B50BE32F Q28474989-7D688F88-5118-430D-8D48-1994FD477E5C Q28478459-F507F0A8-3A51-4A29-8E8C-90A914DE18C6 Q28478779-11A5B20C-B44B-464E-947E-4E2AB7E7581E Q28481233-27242A8B-ED96-418A-A537-E84404E92717 Q28485329-2D471068-3359-4B30-8C9F-B599318F24DC Q28537608-630F0AB5-FC17-49F0-AA0A-5F34C09FDB58 Q28540368-6A984D40-9A67-4F6E-ACB6-6070C067C276 Q28541754-127A0285-4789-48BE-A21A-4DCC4B00A70D Q28543986-9B3DDAF4-B7FE-4C64-81DE-74B068A32B51 Q28552356-2CAE4259-DF7D-4435-8FC5-1FCBB3716BF9 Q30430458-9E987447-65CE-452F-BBF5-DC7D4A724FA4 Q33330469-FED5D63B-1253-4010-90B1-A091356B8E6B Q33622927-EC56331C-F052-4AAF-A4A0-90631AA37171 Q33714377-67901B6E-E70D-4F65-A118-6CF02B58C36E Q33830021-CCD413D7-ED75-44C6-BBDE-5ABF07C9167E Q33899918-6ED42AF8-7DA9-4EA0-B071-CAE69F106461 Q34047780-3866571F-ECD2-42D6-BD83-1A93B0C015AC Q34062608-E7523FFA-203A-4DAD-96D7-29A4AE78F4F1 Q34081115-BC91EC0D-A6F3-4AB8-B0F4-3DB9D58ACFD6 Q34331628-DCAF77BA-EF53-46CC-BCC9-EEB7EDBF761F Q35056873-EFC0ADF5-8054-4A9B-9285-E8D3E4D42930 Q35647691-38CAEB69-71EE-4D90-8EBB-EA655A537C47 Q35789353-FDF938FB-FA9E-4747-9C04-6B64F23BE415 Q35913936-95F8BF8B-18D5-4F97-936D-FFA2801017F4 Q35914785-4E9BE3ED-8DDF-4DE8-9DF8-9A4F03011574 Q35916998-521BB0A0-6FE9-4081-82ED-8F6CF9786F13 Q35947480-B65C38B2-1EE5-4E85-8B55-04A666C2BBEB Q35947607-CC75983C-E3BC-41ED-B276-F64A6C0FE643 Q35990257-D8D5468D-3257-4E2B-B713-4896673509C9 Q36201097-D20538B4-C308-412B-8850-A81094F8BD36 Q36371754-8173E6B0-4D56-4DB6-9A17-62C57F03A0EF Q36507279-BB86F37A-F707-47D7-94B8-990C57D64FC0 Q36525986-171C2668-B11C-436C-9A26-9E00535A639A Q36667504-B965C98B-ED5E-414D-AFB3-4993F0F899D3 Q36779718-FCF50E69-98E1-470E-B91D-87B27D601ECE Q36817632-4C1B7AEB-A7DF-4FFE-9A2C-A33572DCAD76 Q36933330-7E4526E7-C00D-4881-99DD-A67D1F9FFB1F Q37005868-C8697C06-8F19-4B08-945B-F168B3EE9EBF Q37014662-4C410FC8-D085-4EC6-BB85-872464823533

P2860

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.

http://www.wikidata.org/entity/Q34719734

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@ast

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@en

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@nl

type

label

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@ast

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@en

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@nl

prefLabel

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@ast

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@en

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@nl

P1433

Q34719734-82FB5042-AC4A-4B2A-8AE9-92F2E8996129

P1476

Q34719734-B6D5633C-6F1A-4871-B1DA-0B0EC00B6500

P2093

Q34719734-1792D9D8-EE6A-4098-BEAA-4CAF5A1F5CBC

Q34719734-27761D35-2186-45E7-8748-9BF1BCBF804E

Q34719734-2F2383BB-C6FF-4014-9840-33E53E511B5D

Q34719734-3DD678F8-2A2A-46EF-8D73-773770FAAF09

Q34719734-56A8819F-6CC6-4E75-8C0D-80B4F974925A

Q34719734-5DE9ABE7-3F7E-485A-BCDB-D5973F3C5F35

Q34719734-6134060F-6E68-4B1A-84F4-315B7A7C5B7A

Q34719734-695ADBCA-93B2-4F5C-A90B-09C8F7EC1223

Q34719734-76654D7C-0318-4336-A106-A87CE2469533

Q34719734-7F7785CB-BCD7-4C85-AFE5-8CF0E884A93A

P2860

Q34719734-0DF66B30-F6F9-48D9-9F0C-3B1DEA3754A5

Q34719734-163582A1-A43A-4E4E-A94D-5A1593D5A2CC

Q34719734-2754926E-D83F-41C8-9D09-240F260288E5

Q34719734-40820F99-2EAD-4D41-9F15-02645C5757DC

Q34719734-63847010-F3FF-46B4-8D8C-5E8840CA20C4

Q34719734-6CEDD2CD-D6E3-4B7F-9190-5273B0B23F74

Q34719734-78B760FE-657F-4020-9018-818F7961F09F

Q34719734-7CB28D2B-C7AB-4F94-BF6D-DC340ABC8222

Q34719734-7DB561A2-8A17-41B7-B556-1FD7A60E563F

Q34719734-909347FF-BDF7-495E-87B1-FCD07D44589B

P304

Q34719734-EE2BE2DB-3C80-4C29-B654-9A032C6539E2

P31

Q34719734-5998C6DE-EA36-4B48-90EA-143EC03F573C

P356

Q34719734-30E35F53-EBC3-4F4C-B622-F1621C1CB344

P407

Q34719734-20E05E27-3EE5-4939-8305-A18AC270B1E9

P433

Q34719734-80FC1152-D667-4923-BBC0-879CBD4F0536

P478

Q34719734-9A97C11D-65BA-44B1-B9C4-11281E579119

P50

Q34719734-0295477E-FB31-4C65-A886-7A83FE8B6B58

Q34719734-713C9745-C839-4C6B-92CE-23F1E95028DC

Q34719734-8576B77F-B90E-4C3E-A27B-4EE323DDD1D7

Q34719734-FAF34214-4C96-4DFD-A23A-1D4C5562D880

P577

Q34719734-D2B9C392-E0DC-40C7-9028-10A90F7F8C74

P5875

Q34719734-9DB81172-14A8-4E4A-8140-7AD1DD1DF0D8

P698

Q34719734-03593B00-7D9C-4699-BA67-B82699D14167

P921

Q34719734-7AB92337-9535-476F-8AAB-9000B1F51550

P932

Q34719734-9476A817-1A67-4C0D-8C50-EA9BE3CAB1C3

P356

P1433

Journal of Clinical Microbiology

P1476

Blinded, multicenter compariso ...... virus type 1 at low frequency.

@en

P2093

Andrea Kovacs

http://www.w3.org/2001/XMLSchema#string

Cheryl L Jennings

http://www.w3.org/2001/XMLSchema#string

Daniel R Kuritzkes

http://www.w3.org/2001/XMLSchema#string

Don Brambilla

http://www.w3.org/2001/XMLSchema#string

Dwight V Nissley

http://www.w3.org/2001/XMLSchema#string

Elias K Halvas

http://www.w3.org/2001/XMLSchema#string

Grace M Aldrovandi

http://www.w3.org/2001/XMLSchema#string

Ingrid A Beck

http://www.w3.org/2001/XMLSchema#string

J Darren Hazelwood

http://www.w3.org/2001/XMLSchema#string

James Bremer

http://www.w3.org/2001/XMLSchema#string

P2860

3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures.

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors.

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.

Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants.

Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions.

P304

2612-2614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00449-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Karin J Metzner

Richard Y. Zhao

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6960534

http://www.w3.org/2001/XMLSchema#string

P698

16825395

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

1489464

http://www.w3.org/2001/XMLSchema#string